The Luxembourg BioHealth Cluster aims to strengthen and capitalise on the national strategy developed by Luxembourg’s government to achieve scientific excellence in molecular diagnostics, the cornerstone of personalised medicine. Its members are R&D companies, public research organisations, laboratories, hospitals and other actors (patients associations, service and capital providers, etc.) whose activities are related to health sciences and technologies.
With a principal focus on molecular diagnostics, the Cluster’s umbrella also covers other research and business fields that are key elements in an integrated patientbased personalised medicine approach, such as new therapeutics, bioinformatics and eHealth. Supporting this dynamic and steadily growing biocommunity is the main objective. Therefore, the Cluster provides its members with a portfolio of added-value activities and services to support them in their daily R&D, innovation and business challenges and to increase their national and international visibility and attractiveness.